Sufian S, Arnez A, Labropoulos N, Nguyen K, Satwah V, Marquez J, Chowla A, Lakhanpal S
Center for Vein Restoration, Greenbelt, MD, USA
Center for Vein Restoration, Greenbelt, MD, USA.
Phlebology. 2015 Dec;30(10):724-8. doi: 10.1177/0268355514556142. Epub 2014 Oct 17.
To evaluate the results of radiofrequency ablation (RFA) of the great saphenous vein (GSV) using one versus two 20 s energy cycle treatment in the proximal 7 cm segment of the GSV.
All patients who underwent RFA of the GSV from 1 May 2013 to 30 September 2013 in eight of our vein centers were included. Duplex ultrasound scans (DUSs) were performed prior to treatment on all patients and 2-3 days, and 1 month after procedure. Demographic data, GSV diameters, and other relevant data were recorded. Clinical, Etiologic, Anatomic, Pathologic (CEAP) classification and Venous Clinical Severity Scores (VCSSs) were determined prior to ablation and one month later. Patients who developed endovenous heat induced thrombosis (EHIT) were followed till resolution.
A total of 205 patients had one cycle treatment (group A) and 204 had two cycle treatment (group B). The two groups were comparable in their demography, CEAP classification, and VCSS scores. The rate of failure of ablation and incidence of EHIT were also not significantly different. The incidence of complications was low, <5% in both groups and all were minor.
Two cycle treatment of the proximal GSV for vein ablation does not improve the success rate of vein closure in the short term, compared to one cycle treatment. It also does not increase the risks of DVT, EHIT, major bleeding, and other complications. However, we do not know at what diameter two cycles may be superior to one cycle.
评估在大隐静脉(GSV)近端7厘米段使用一个与两个20秒能量周期治疗进行大隐静脉射频消融(RFA)的效果。
纳入2013年5月1日至2013年9月30日在我们八个静脉中心接受GSV射频消融的所有患者。所有患者在治疗前、治疗后2 - 3天以及1个月时进行双功超声扫描(DUS)。记录人口统计学数据、GSV直径及其他相关数据。在消融前及1个月后确定临床、病因、解剖、病理(CEAP)分类和静脉临床严重程度评分(VCSS)。对发生静脉内热诱导血栓形成(EHIT)的患者进行随访直至血栓溶解。
共有205例患者接受一个周期治疗(A组),204例接受两个周期治疗(B组)。两组在人口统计学、CEAP分类和VCSS评分方面具有可比性。消融失败率和EHIT发生率也无显著差异。并发症发生率较低,两组均<5%,且均为轻微并发症。
与一个周期治疗相比,大隐静脉近端进行两个周期治疗用于静脉消融在短期内并不能提高静脉闭合成功率。它也不会增加深静脉血栓形成、EHIT、大出血及其他并发症的风险。然而,我们尚不清楚在何种直径下两个周期可能优于一个周期。